trending Market Intelligence /marketintelligence/en/news-insights/trending/n2vvJzZnuB4ZaATZQNxHtg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Fitch affirms Amgen's long-term issuer default rating

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Fitch affirms Amgen's long-term issuer default rating

Fitch Ratings affirmed Amgen Inc.'s long-term issuer default rating at BBB.

The outlook on the rating is stable.

The ratings apply to $36.7 billion of debt outstanding at Sept. 30.

Fitch said Amgen's BBB rating reflects the smaller and less diversified nature of the company's operating profile comparative to larger innovative industry peers, Pfizer Inc. and Merck & Co. Inc.